Evidence map›Paper›PMID 39808405›Full record

ArticlePharmacological reports : PR2025

[

Krishna K Gollapelli, Ivan Krizan, Bhuvanachandra Bhoopal, Naresh Damuka, Carson Moriarty, Mack Miller, Kiran K Solingapuram Sai, Robert W Gould

Abstract read
In one paragraph

Article in Pharmacological reports : PR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Krishna K Gollapelli *Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Ivan Krizan *Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Bhuvanachandra BhoopalDepartment of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Naresh DamukaDepartment of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Carson MoriartyDepartment of Translational Neuroscience, Center for Addiction Research, Wake Forest University School of Medicine, 115 South Chestnut St, Winston-Salem, NC, 27101, USA.
Mack MillerDepartment of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Kiran K Solingapuram SaiDepartment of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA. ksolinga@wakehealth.edu.
Robert W GouldDepartment of Translational Neuroscience, Center for Addiction Research, Wake Forest University School of Medicine, 115 South Chestnut St, Winston-Salem, NC, 27101, USA. rgould@wakehealth.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCocaine Use Disorder (CUD) remains a significant problem in the United States, with high rates of relapse and no present FDA-approved treatment. The acetylcholine neurotransmitter system, specifically through modulation of muscarinic acetylcholine receptor (mAChR) function, has shown promise as a therapeutic target for multiple aspects of CUD. Enhancement of the M

objectivesTo evaluate the effects of cocaine self-administration on M

methodsSprague-Dawley rats self-administered cocaine or sucrose pellets for 15 days under 2-h or 4-h sessions followed by PET imaging with [

resultsCumulative cocaine intake ranged between 324 and 776 mg/kg. Cocaine self-administration was associated with significantly lower [

conclusionsThese results suggest that cocaine self-administration decreases M

Indexed as

BrainCocaineCocaine-Related DisordersPositron-Emission TomographyReceptor, Muscarinic M4AnimalsCarbon RadioisotopesMaleRatsRats, Sprague-DawleySelf AdministrationCarbon RadioisotopesCocaineReceptor, Muscarinic M4[11C]MK-6884Cocaine self-administrationCocaine use disorder (CUD)M4 mAChRPET imagingRadiochemistry

Identifiers

PMID39808405
PMCPMC11911261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.